U.S. flag

An official website of the United States government

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
 
Genetics & Genomics Programs

COVID-19 GWAS Results -- for public download/use

This site compiles COVID-19 genetic scan results for immediate public download and use from any source permitting such use. Users may cite this resource by referencing the HGG Advances publication Thibord et al. 2022. Right click links provided here and select “open link in a new tab” to stay on this webpage.

Format changes: 1) some variants have scientific format POS, i.e. 1.2e+07 for 12000000, now changed to integer, 2) 01, 02,…, 09 in CHR, now changed to 1, 2,.., 9. Changes are made from 01/04/2021 release.

Prior to 07/14/2020: The use of the term “positive” below denotes a positive or assumed positive COVID-19 case based on study definitions. “Negative” indicates someone who has tested negative or presumed negative based on study definitions for COVID-19. “Unknown” indicates population control samples who may not have been tested or may not yet have results.

Between 07/14/2020 and 09/08/2020: COVID-19 deaths (ICD 10 U071) or inpatient diagnosis of COVID-19 (ICD 10 U071) were also added to “positive”. When new death data are released by UK BioBank, six COVID-19 death GWAS will be conducted in addition to COVID-19 GWAS.

From 10/16/2020 and on: COVID-19 deaths (ICD 10 U071), inpatient diagnosis of COVID-19 (ICD 10 U071), primary care clinical data indicating COVID-19 (both TPP/CTV3 and EMIS/SNOMED CT coding systems – see below) were also added to “positive”.

COVID-19 in TPP/CTV3 coding system (01/31/2020 or later)
Y228d: Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 confirmed by laboratory test (situation)
Y20d1: Severe acute respiratory syndrome coronavirus 2 detected (finding)
Y20fa: Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 (disorder)
Y210a: Pneumonia caused by severe acute respiratory syndrome coronavirus 2 (disorder)
Y210b: Infection of upper respiratory tract caused by severe acute respiratory syndrome coronavirus 2 (disorder)
Y210e: Detection of severe acute respiratory syndrome coronavirus 2 using polymerase chain reaction technique (procedure)
Y23f7: SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) detection result positive

COVID-19 in EMIS/SNOMED CT coding system (01/31/2020 or later)
EMISNQCO303: 2019-nCoV (Wuhan) infection
186747009: Coronavirus infection (disorder)
12802201000006101: Confirmed 2019-nCoV (novel coronavirus) infection
1240581000000104: 2019-nCoV (novel coronavirus) detected
1300721000000109: Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 confirmed by laboratory test (situation)
1240751000000100: Disease caused by 2019-nCoV (novel coronavirus)
1240561000000108: Encephalopathy caused by 2019-nCoV (novel coronavirus)
1240571000000101: Gastroenteritis caused by 2019-nCoV (novel coronavirus)
1240531000000103: Myocarditis caused by 2019-nCoV (novel coronavirus)
1240521000000100: Otitis media caused by 2019-nCoV (novel coronavirus)
1240551000000105: Pneumonia caused by 2019-nCoV (novel coronavirus)
1240541000000107: Upper respiratory tract infection caused by 2019-nCoV (novel coronavirus)
1240511000000106: Detection of 2019-nCoV (novel coronavirus) using polymerase chain reaction technique
1240381000000105: Severe acute respiratory syndrome coronavirus 2 (organism)
1321541000000108: SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) IgG detection result positive (added since 02/24/2021)
1321551000000106: SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) IgM detection result positive (added since 02/24/2021)
1300731000000106: COVID-19 confirmed using clinical diagnostic criteria (added since 02/24/2021)

From 11/03/2020 and on: We added hospitalized COVID-19 GWAS and severe COVID-19 GWAS with primary care data (both TPP/CTV3 and EMIS/SNOMED CT) being released by UKBB. A hospitalized COVID-19 case is defined by a sample with inpatient diagnosis of COVID-19 (ICD 10 U071). A severe COVID-19 case is defined by a sample with COVID-19 death (ICD 10 U071) or with inpatient diagnosis of both COVID-19 and dependence on respirator (ICD 10 Z991 and Z9911) in the same instance index, or a COVID-10 case with advanced respiratory support (from inpatient critical care data). Due to limited case samples, currently we only conducted both hospitalized and sever COVID-19 GWAS for European and overall samples in UKBB – with 3 additional non-European GWAS for hospitalized COVID-19.

From 02/24/2021 and on: We added two COVID-19 GWAS in UKBB EAS samples, and three hospitalized COVID-19 GWAS for each of the UKBB AFR, SAS and OTHERS samples.

Note OTHERS samples include samples that are not EUR, AFR and SAS, thus EAS are included in OTHERS.

After each COVID-19 release of UK Biobank data (https://biobank.ctsu.ox.ac.uk/crystal/exinfo.cgi?src=timelines_all) we are calculating GWAS summary statistics and releasing them to this site. GWAS were conducted with SAIGE (https://github.com/weizhouUMICH/SAIGE) adjusted for baseline age, sex and 10 principal components.

  • Two analyses (06/05/2020 or earlier):
    • Positive COVID-19 tests vs. Negative only COVID-19 tests (files with name whites)
    • Positive COVID-19 tests vs. All UKBioBank EA with either negative tests or no known tests (files with name “ALLwhites”)
  • Eighteen analyses (06/18/2020):
    • COVID-19 positive vs. COVID-19 negative in ALL UKBB tested samples (files with name UKBB_covid19_ALLtested)
    • COVID-19 positive vs. COVID-19 negative or untested in ALL UKBB samples (files with name UKBB_covid19_ALL)
    • COVID-19 positive vs. COVID-19 negative in European (EUR) UKBB tested samples (files with name UKBB_covid19_EURtested)
    • COVID-19 positive vs. COVID-19 negative or untested in European (EUR) UKBB samples (files with name UKBB_covid19_EUR)
    • COVID-19 positive vs. COVID-19 negative in ALL Female UKBB tested samples (files with name UKBB_covid19_ALLtested_F)
    • COVID-19 positive vs. COVID-19 negative or untested in ALL Female UKBB samples (files with name UKBB_covid19_ALL_F)
    • COVID-19 positive vs. COVID-19 negative in European (EUR) Female UKBB tested samples (files with name UKBB_covid19_EURtested_F)
    • COVID-19 positive vs. COVID-19 negative or untested in European (EUR) Female UKBB samples (files with name UKBB_covid19_EUR_F)
    • COVID-19 positive vs. COVID-19 negative in ALL Male UKBB tested samples (files with name UKBB_covid19_ALLtested_M)
    • COVID-19 positive vs. COVID-19 negative or untested in ALL Male UKBB samples (files with name UKBB_covid19_ALL_M)
    • COVID-19 positive vs. COVID-19 negative in European (EUR) Male UKBB tested samples (files with name UKBB_covid19_EURtested_M)
    • COVID-19 positive vs. COVID-19 negative or untested in European (EUR) Male UKBB samples (files with name UKBB_covid19_EUR_M)
    • COVID-19 positive vs. COVID-19 negative in African (AFR) UKBB tested samples (files with name UKBB_covid19_AFRtested)
    • COVID-19 positive vs. COVID-19 negative or untested in African (AFR) UKBB samples (files with name UKBB_covid19_AFR)
    • COVID-19 positive vs. COVID-19 negative in South Asian (SAS) UKBB tested samples (files with name UKBB_covid19_SAStested)
    • COVID-19 positive vs. COVID-19 negative or untested in South Asian (SAS) UKBB samples (files with name UKBB_covid19_SAS)
    • COVID-19 positive vs. COVID-19 negative in OTHERS ancestry UKBB tested samples (files with name UKBB_covid19_OTHERStested)
    • COVID-19 positive vs. COVID-19 negative or untested in OTHERS ancestry UKBB samples (files with name UKBB_covid19_OTHERS)
  • Six COVID-19 death analyses in addition to above 18 analyses (07/14/2020):
    • COVID-19 death vs. COVID-19 negative or untested in ALL UKBB samples (files with name UKBB_death_ALL)
    • COVID-19 death vs. COVID-19 negative or untested in European (EUR) UKBB samples (files with name UKBB_death_EUR)
    • COVID-19 death vs. COVID-19 positive survivors in ALL UKBB tested positive samples (files with name UKBB_death_ALLpstv)
    • COVID-19 death vs. COVID-19 positive survivors in European (EUR) UKBB tested positive samples (files with name UKBB_death_EURpstv)
    • COVID-19 death vs. COVID-19 positive survivors and negative in ALL UKBB tested samples (files with name UKBB_death_ALLtested)
    • COVID-19 death vs. COVID-19 positive survivors and negative in European (EUR) UKBB tested samples (files with name UKBB_death_EURtested)
  • Two analyses in addition to the above 24 analyses (08/04/2020):
    • COVID-19 positive vs. COVID-19 negative in non-European (nEUR) UKBB tested samples (files with name UKBB_covid19_nEURtested)
    • COVID-19 positive vs. COVID-19 negative or untested in non-European (nEUR) UKBB samples (files with name UKBB_covid19_nEUR)
  • Twenty-one hospitalized COVID-19 analyses (11/03/2020):
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive in ALL UKBB tested positive samples (files with name UKBB_hsptl_ALLpstv)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive or COVID-19 negative in ALL UKBB tested samples (files with name UKBB_hsptl_ALLtested)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive, COVID-19 negative or untested in ALL UKBB samples (files with name UKBB_hsptl_ALL)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive in European (EUR) UKBB tested positive samples (files with name UKBB_hsptl_EURpstv)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive or COVID-19 negative in EUR UKBB tested samples (files with name UKBB_hsptl_EURtested)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive, COVID-19 negative or untested in EUR UKBB samples (files with name UKBB_hsptl_EUR)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive in non-European (nEUR) UKBB tested positive samples (files with name UKBB_hsptl_nEURpstv)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive or COVID-19 negative in nEUR UKBB tested samples (files with name UKBB_hsptl_nEURtested)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive, COVID-19 negative or untested in nEUR UKBB samples (files with name UKBB_hsptl_nEUR)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive in ALL Female UKBB tested positive samples (files with name UKBB_hsptl_ALLpstv_F)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive or COVID-19 negative in ALL Female UKBB tested samples (files with name UKBB_hsptl_ALLtested_F)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive, COVID-19 negative or untested in ALL Female UKBB samples (files with name UKBB_hsptl_ALL_F)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive in EUR Female UKBB tested positive samples (files with name UKBB_hsptl_EURpstv_F)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive or COVID-19 negative in EUR Female UKBB tested samples (files with name UKBB_hsptl_EURtested_F)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive, COVID-19 negative or untested in EUR Female UKBB samples (files with name UKBB_hsptl_EUR_F)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive in ALL Male UKBB tested positive samples (files with name UKBB_hsptl_ALLpstv_M)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive or COVID-19 negative in ALL Male UKBB tested samples (files with name UKBB_hsptl_ALLtested_M)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive, COVID-19 negative or untested in ALL Male UKBB samples (files with name UKBB_hsptl_ALL_M)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive in EUR Male UKBB tested positive samples (files with name UKBB_hsptl_EURpstv_M)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive or COVID-19 negative in EUR Male UKBB tested samples (files with name UKBB_hsptl_EURtested_M)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive, COVID-19 negative or untested in EUR Male UKBB samples (files with name UKBB_hsptl_EUR_M)
  • Eighteen severe COVID-19 analyses (11/03/2020):
    • Severe COVID-19 positive vs. non-severe COVID-19 positive in ALL UKBB tested positive samples (files with name UKBB_severe_ALLpstv)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive or COVID-19 negative in ALL UKBB tested samples (files with name UKBB_severe_ALLtested)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive, COVID-19 negative or untested in ALL UKBB samples (files with name UKBB_severe_ALL)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive in European (EUR) UKBB tested positive samples (files with name UKBB_severe_EURpstv)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive or COVID-19 negative in EUR UKBB tested samples (files with name UKBB_severe_EURtested)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive, COVID-19 negative or untested in EUR UKBB samples (files with name UKBB_severe_EUR)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive in ALL Female UKBB tested positive samples (files with name UKBB_severe_ALLpstv_F)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive or COVID-19 negative in ALL Female UKBB tested samples (files with name UKBB_severe_ALLtested_F)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive, COVID-19 negative or untested in ALL Female UKBB samples (files with name UKBB_severe_ALL_F)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive in EUR Female UKBB tested positive samples (files with name UKBB_severe_EURpstv_F)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive or COVID-19 negative in EUR Female UKBB tested samples (files with name UKBB_severe_EURtested_F)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive, COVID-19 negative or untested in EUR Female UKBB samples (files with name UKBB_severe_EUR_F)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive in ALL Male UKBB tested positive samples (files with name UKBB_severe_ALLpstv_M)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive or COVID-19 negative in ALL Male UKBB tested samples (files with name UKBB_severe_ALLtested_M)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive, COVID-19 negative or untested in ALL Male UKBB samples (files with name UKBB_severe_ALL_M)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive in EUR Male UKBB tested positive samples (files with name UKBB_severe_EURpstv_M)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive or COVID-19 negative in EUR Male UKBB tested samples (files with name UKBB_severe_EURtested_M)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive, COVID-19 negative or untested in EUR Male UKBB samples (files with name UKBB_severe_EUR_M)
  • Two additional COVID-19 analyses (02/24/2021):
    • COVID-19 positive vs. COVID-19 negative in East Asian (EAS) UKBB tested samples (files with name UKBB_covid19_EAStested)
    • COVID-19 positive vs. COVID-19 negative or untested in East Asian (EAS) UKBB samples (files with name UKBB_covid19_EAS)
  • Nine additional hospitalized COVID-19 analyses (02/24/2021):
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive in African (AFR) UKBB tested positive samples (files with name UKBB_hsptl_AFRpstv)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive or COVID-19 negative in AFR UKBB tested samples (files with name UKBB_hsptl_AFRtested)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive, COVID-19 negative or untested in AFR UKBB samples (files with name UKBB_hsptl_AFR)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive in South Asian (SAS) UKBB tested positive samples (files with name UKBB_hsptl_SASpstv)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive or COVID-19 negative in SAS UKBB tested samples (files with name UKBB_hsptl_SAStested)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive, COVID-19 negative or untested in SAS UKBB samples (files with name UKBB_hsptl_SAS)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive in other ancestry (OTHERS) UKBB tested positive samples (files with name UKBB_hsptl_OTHERSpstv)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive or COVID-19 negative in OTHERS UKBB tested samples (files with name UKBB_hsptl_OTHERStested)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive, COVID-19 negative or untested in OTHERS UKBB samples (files with name UKBB_hsptl_OTHERS)

Summary statistics are for UK Biobank (v.3) imputed genome-wide association (GWAS) studies of COVID-19 test positives with variant filters of imputation quality INFO score >0.3, minor allele count (MAC) > 2, minor allele frequency > 0.0001. Note allele2 is coded allele. See SAIGE output description here: https://github.com/weizhouUMICH/SAIGE/wiki/Genetic-association-tests-using-SAIGE.

Ellinghaus, Degenhardt et al.
Meta-analysis of Spanish and Italian COVID19 cases with respiratory failure
NOTE: full GWAS files are GRCh38 build position whereas top results and annotated files have been Lifted Over to GRCh37.

COVID-19 Host Genetics initiative results provided under Creative Commons License. This includes meta-analyses of international case/control samples with a larger sample size than UKBB alone. These analyses may also have greater test/population ascertainment and genetic heterogeneity effects. If you have samples to contribute we urge you to consider joining. See also https://www.covid19hg.org/blog/ and https://www.nature.com/articles/s41431-020-0636-6

GenOMICC
GWAS of critically ill COVID patients. See also: https://genomicc.org/ and https://pubmed.ncbi.nlm.nih.gov/33307546/

Dube et al.
GWAS of time to remission of symptoms in the COVID colchicine trial COLCORONA. Before using data please see their terms and conditions here: https://pheweb.statgen.org/terms/pheweb/terms.html

Annotation of all top results P<1E-5 was done from several sources:

All files are in compressed Gzip format.
Send questions, comments or requests to add data or analysis to: ming-huei.chen@nih.gov, florian.thibord@nih.gov, and johnsonad2@nih.gov

Data Source Release Date Description # Cases / Controls Ancestry    Sex    # variants (Million) # Top (P<1E-5) Summary Stats(full) Top Annotated Top in Grasp Top in EBI Top in GTeX Top in eQTLdb     Comments    
UKBB 06.18.21 Positive vs. Population 557 / 7,087 African M and F 43.68M 420 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Positive vs. Negative (tested) 557 / 1,281 African M and F 32.20M 199 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Positive vs. Population 18,481 / 468,839 Mixed M and F 47.70M 972 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Positive vs. Population 9,757 / 254,472 Mixed F 47.88M 602 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Positive vs. Population 8,724 / 214,367 Mixed M 47.45M 556 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Positive vs. Negative (tested) 18,481 / 86,435 Mixed M and F 48.14M 706 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Positive vs. Negative (tested) 9,757 / 46,737 Mixed F 48.35M 485 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Positive vs. Negative (tested) 8,724 / 39,698 Mixed M 47.77M 479 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Positive vs. Negative (tested) 47 / 176 East Asian M and F 305.99K 71 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Positive vs. Population 16,551 / 442,699 European M and F 38.06M 856 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Positive vs. Population 8,767 / 240,532 European F 38.11M 412 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Positive vs. Population 7,784 / 202,167 European M 37.98M 419 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Positive vs. Negative (tested) 16,551 / 81,826 European M and F 38.08M 466 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Positive vs. Negative (tested) 8,767 / 44,248 European F 38.09M 314 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Positive vs. Negative (tested) 7,784 / 37,578 European M 37.98M 399 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Positive vs. Population 1,930 / 26,140 Non European M and F 66.62M 747 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Positive vs. Negative (tested) 1,930 / 4,609 Non European M and F 52.38M 545 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Positive vs. Population 563 / 10,446 Other M and F 61.41M 752 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Positive vs. Negative (tested) 563 / 1,812 Other M and F 35.05M 296 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Positive vs. Population 810 / 8,607 South Asian M and F 41.98M 325 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Positive vs. Negative (tested) 810 / 1,516 South Asian M and F 25.18M 137 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 142 / 7,502 African M and F 43.68M 414 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive 142 / 415 African M and F 23.99M 271 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 142 / 1,696 African M and F 32.20M 301 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 3,260 / 484,060 Mixed M and F 47.70M 722 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 1,343 / 262,886 Mixed F 47.88M 395 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 1,917 / 221,174 Mixed M 47.45M 531 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive 3,260 / 15,221 Mixed M and F 51.15M 765 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive 1,343 / 8,414 Mixed F 45.13M 486 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive 1,917 / 6,807 Mixed M 43.10M 330 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 3,260 / 101,656 Mixed M and F 48.14M 698 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 1,343 / 55,151 Mixed F 48.35M 393 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 1,917 / 46,505 Mixed M 47.77M 676 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 2,884 / 456,366 European M and F 38.06M 757 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 1,181 / 248,118 European F 38.11M 325 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 1,703 / 208,248 European M 37.98M 370 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive 2,884 / 13,667 European M and F 37.83M 584 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive 1,181 / 7,586 European F 32.32M 309 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive 1,703 / 6,081 European M 30.99M 333 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 2,884 / 95,493 European M and F 38.08M 665 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 1,181 / 51,834 European F 38.09M 287 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 1,703 / 43,659 European M 37.98M 624 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 376 / 27,694 Non European M and F 66.62M 597 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive 376 / 1,554 Non European M and F 34.25M 335 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 376 / 6,163 Non European M and F 52.38M 442 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 103 / 10,906 Other M and F 61.41M 478 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive 103 / 460 Other M and F 21.46M 165 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 103 / 2,272 Other M and F 35.05M 217 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 131 / 9,286 South Asian M and F 41.98M 235 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive 131 / 679 South Asian M and F 16.84M 158 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 131 / 2,195 South Asian M and F 25.18M 163 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive vs. Population 532 / 7,112 African M and F 42.11M 354 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive vs. Negative (tested) 532 / 995 African M and F 29.67M 191 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive vs. Population 17,657 / 469,663 Mixed M and F 47.70M 901 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive vs. Population 9,305 / 254,924 Mixed F 47.88M 579 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive vs. Population 8,352 / 214,739 Mixed M 47.45M 515 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive vs. Negative (tested) 17,657 / 68,329 Mixed M and F 48.18M 734 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive vs. Negative (tested) 9,305 / 36,945 Mixed F 48.41M 560 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive vs. Negative (tested) 8,352 / 31,384 Mixed M 47.76M 509 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive vs. Population 47 / 1,456 East Asian M and F 18.24M 87 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive vs. Negative (tested) 47 / 132 East Asian M and F 9.02M 33 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive vs. Population 15,815 / 443,435 European M and F 38.06M 814 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive vs. Population 8,363 / 240,936 European F 38.11M 442 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive vs. Population 7,452 / 202,499 European M 37.98M 490 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive vs. Negative (tested) 15,815 / 64,744 European M and F 38.02M 468 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive vs. Negative (tested) 8,363 / 34,997 European F 38.01M 325 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive vs. Negative (tested) 7,452 / 29,747 European M 37.91M 409 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive vs. Population 535 / 10,474 Other M and F 59.08M 615 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive vs. Negative (tested) 535 / 1,386 Other M and F 31.11M 282 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive vs. Population 775 / 8,642 South Asian M and F 40.39M 319 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive vs. Negative (tested) 775 / 1,204 South Asian M and F 22.73M 133 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive vs. Population 1,842 / 26,228 Non European M and F 64.13M 729 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive vs. Negative (tested) 1,842 / 3,585 Non European M and F 47.42M 408 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive and Death vs. Population 1,104 / 486,216 Mixed M and F 47.70M 489 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive and Death vs. Positive Survivor 1,104 / 16,553 Mixed M and F 51.10M 494 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive and Death vs. Tested Survivor 1,104 / 84,882 Mixed M and F 48.18M 564 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive and Death vs. Population 1,001 / 458,249 European M and F 38.06M 344 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive and Death vs. Positive Survivor 1,001 / 14,814 European M and F 37.82M 206 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Positive and Death vs. Tested Survivor 1,001 / 79,558 European M and F 38.02M 276 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 139 / 7,505 African M and F 43.68M 384 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive 139 / 393 African M and F 23.71M 277 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 139 / 1,388 African M and F 30.79M 292 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 3,109 / 484,211 Mixed M and F 47.70M 719 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 1,282 / 262,947 Mixed F 47.88M 450 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 1,827 / 221,264 Mixed M 47.45M 442 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive 3,109 / 14,548 Mixed M and F 51.10M 643 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive 1,282 / 8,023 Mixed F 44.41M 487 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive 1,827 / 6,525 Mixed M 42.49M 360 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 3,109 / 82,877 Mixed M and F 48.18M 692 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 1,282 / 44,968 Mixed F 48.41M 424 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 1,827 / 37,909 Mixed M 47.76M 523 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 2,746 / 456,504 European M and F 38.06M 764 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 1,126 / 248,173 European F 38.11M 350 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 1,620 / 208,331 European M 37.98M 410 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive 2,746 / 13,069 European M and F 37.82M 561 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive 1,126 / 7,237 European F 31.81M 283 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive 1,620 / 5,832 European M 30.54M 303 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 2,746 / 77,813 European M and F 38.02M 627 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 1,126 / 42,234 European F 38.01M 289 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 1,620 / 35,579 European M 37.91M 499 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 101 / 10,908 Other M and F 61.41M 481 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive 101 / 434 Other M and F 21.05M 171 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 101 / 1,820 Other M and F 32.32M 189 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 123 / 9,294 South Asian M and F 41.98M 178 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive 123 / 652 South Asian M and F 16.59M 141 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 123 / 1,856 South Asian M and F 23.57M 155 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 363 / 27,707 Non European M and F 66.62M 568 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive 363 / 1,479 Non European M and F 33.68M 331 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 363 / 5,064 Non European M and F 49.25M 455 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Severe Positive vs. Non-Severe Positive or Negative or Untested 1,244 / 486,076 Mixed M and F 47.70M 739 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Severe Positive vs. Non-Severe Positive or Negative or Untested 439 / 263,790 Mixed F 47.88M 268 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Severe Positive vs. Non-Severe Positive or Negative or Untested 805 / 222,286 Mixed M 47.45M 457 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Severe Positive vs. Non-Severe Positive 1,244 / 16,413 Mixed M and F 51.10M 886 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Severe Positive vs. Non-Severe Positive 439 / 8,866 Mixed F 44.41M 320 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Severe Positive vs. Non-Severe Positive 805 / 7,547 Mixed M 42.49M 431 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Severe Positive vs. Non-Severe Positive or Negative 1,244 / 84,742 Mixed M and F 48.18M 1009 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Severe Positive vs. Non-Severe Positive or Negative 439 / 45,811 Mixed F 48.41M 257 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Severe Positive vs. Non-Severe Positive or Negative 805 / 38,931 Mixed M 47.76M 591 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Severe Positive vs. Non-Severe Positive or Negative or Untested 1,120 / 458,130 European M and F 38.06M 583 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Severe Positive vs. Non-Severe Positive or Negative or Untested 387 / 248,912 European F 38.11M 195 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Severe Positive vs. Non-Severe Positive or Negative or Untested 733 / 209,218 European M 37.98M 362 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Severe Positive vs. Non-Severe Positive 1,120 / 14,695 European M and F 37.82M 357 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Severe Positive vs. Non-Severe Positive 387 / 7,976 European F 31.81M 203 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Severe Positive vs. Non-Severe Positive 733 / 6,719 European M 30.54M 260 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Severe Positive vs. Non-Severe Positive or Negative 1,120 / 79,439 European M and F 38.02M 541 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Severe Positive vs. Non-Severe Positive or Negative 387 / 42,973 European F 38.01M 227 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.09.21 Severe Positive vs. Non-Severe Positive or Negative 733 / 36,466 European M 37.91M 346 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Positive vs. Population 519 / 7,125 African M and F 43.68M 376 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Positive vs. Negative (tested) 519 / 889 African M and F 30.18M 237 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Positive vs. Population 16,586 / 470,734 Mixed M and F 47.70M 854 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Positive vs. Population 8,737 / 255,492 Mixed F 47.88M 584 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Positive vs. Population 7,849 / 215,242 Mixed M 47.45M 507 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Positive vs. Negative (tested) 16,586 / 53,376 Mixed M and F 48.81M 679 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Positive vs. Negative (tested) 8,737 / 28,511 Mixed F 49.16M 664 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Positive vs. Negative (tested) 7,849 / 24,865 Mixed M 48.22M 450 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Positive vs. Population 43 / 1,460 East Asian M and F 18.91M 119 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Positive vs. Negative (tested) 43 / 110 East Asian M and F 9.07M 102 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Positive vs. Population 14,810 / 444,440 European M and F 38.06M 795 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Positive vs. Population 7,823 / 241,476 European F 38.11M 416 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Positive vs. Population 6,987 / 202,964 European M 37.98M 545 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Positive vs. Negative (tested) 14,810 / 50,320 European M and F 38.11M 424 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Positive vs. Negative (tested) 7,823 / 26,824 European F 38.12M 392 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Positive vs. Negative (tested) 6,987 / 23,496 European M 37.98M 388 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Positive vs. Population 1,776 / 26,294 Non European M and F 66.62M 696 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Positive vs. Negative (tested) 1,776 / 3,056 Non European M and F 47.34M 396 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Positive vs. Population 516 / 10,493 Other M and F 61.41M 572 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Positive vs. Negative (tested) 516 / 1,134 Other M and F 30.64M 291 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Positive vs. Population 741 / 8,676 South Asian M and F 41.98M 332 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Positive vs. Negative (tested) 741 / 1,033 South Asian M and F 22.58M 121 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 1,966 / 485,354 Mixed M and F 47.70M 515 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 760 / 263,469 Mixed F 47.88M 386 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 1,206 / 221,885 Mixed M 47.45M 500 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Hospitalized Positive vs. Non-Hospitalized Positive 1,966 / 14,620 Mixed M and F 51.30M 520 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Hospitalized Positive vs. Non-Hospitalized Positive 760 / 7,977 Mixed F 43.73M 353 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Hospitalized Positive vs. Non-Hospitalized Positive 1,206 / 6,643 Mixed M 41.76M 600 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 1,966 / 67,996 Mixed M and F 48.81M 528 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 760 / 36,488 Mixed F 49.16M 409 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 1,206 / 31,508 Mixed M 48.22M 629 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 1,755 / 457,495 European M and F 38.06M 485 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 676 / 248,623 European F 38.11M 383 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 1,079 / 208,872 European M 37.98M 492 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Hospitalized Positive vs. Non-Hospitalized Positive 1,755 / 13,055 European M and F 37.86M 426 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Hospitalized Positive vs. Non-Hospitalized Positive 676 / 7,147 European F 31.18M 282 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Hospitalized Positive vs. Non-Hospitalized Positive 1,079 / 5,908 European M 29.91M 391 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 1,755 / 63,375 European M and F 38.11M 457 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 676 / 33,971 European F 38.12M 426 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 04.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 1,079 / 29,404 European M 37.98M 500 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive vs. Population 496 / 7,148 African M and F 43.68M 399 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive vs. Negative (tested) 496 / 809 African M and F 29.60M 198 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive vs. Population 15,738 / 471,582 Mixed M and F 47.70M 896 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive vs. Population 8,258 / 255,971 Mixed F 47.88M 664 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive vs. Population 7,480 / 215,611 Mixed M 47.45M 495 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive vs. Negative (tested) 15,738 / 47,413 Mixed M and F 48.93M 697 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive vs. Negative (tested) 8,258 / 25,373 Mixed F 49.27M 620 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive vs. Negative (tested) 7,480 / 22,040 Mixed M 48.35M 460 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive vs. Population 41 / 1,462 East Asian M and F 18.91M 125 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive vs. Negative (tested) 41 / 94 East Asian M and F 8.84M 72 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive vs. Population 14,054 / 445,196 European M and F 38.06M 789 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive vs. Population 7,396 / 241,903 European F 38.11M 429 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive vs. Population 6,658 / 203,293 European M 37.98M 433 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive vs. Negative (tested) 14,054 / 44,646 European M and F 38.10M 438 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive vs. Negative (tested) 7,396 / 23,847 European F 38.08M 504 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive vs. Negative (tested) 6,658 / 20,799 European M 37.94M 323 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive vs. Population 1,684 / 26,386 Non European M and F 66.62M 811 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive vs. Negative (tested) 1,684 / 2,767 Non European M and F 46.01M 322 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive vs. Population 495 / 10,514 Other M and F 61.41M 529 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive vs. Negative (tested) 495 / 1,020 Other M and F 29.72M 397 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive vs. Population 693 / 8,724 South Asian M and F 41.98M 387 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive vs. Negative (tested) 693 / 938 South Asian M and F 21.84M 110 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive and Death vs. Population 828 / 486,492 Mixed M and F 47.70M 438 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive and Death vs. Positive Survivor 828 / 14,910 Mixed M and F 51.30M 629 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive and Death vs. Tested Survivor 828 / 62,323 Mixed M and F 48.93M 434 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive and Death vs. Population 758 / 458,492 European M and F 38.06M 371 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive and Death vs. Positive Survivor 758 / 13,296 European M and F 37.33M 243 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Positive and Death vs. Tested Survivor 758 / 57,942 European M and F 38.10M 340 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 77 / 7,567 African M and F 43.68M 317 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive 77 / 419 African M and F 23.28M 257 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 77 / 1,228 African M and F 29.60M 262 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 1,916 / 485,404 Mixed M and F 47.70M 473 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 735 / 263,494 Mixed F 47.88M 323 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 1,181 / 221,910 Mixed M 47.45M 521 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive 1,916 / 13,822 Mixed M and F 51.30M 612 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive 735 / 7,523 Mixed F 42.94M 349 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive 1,181 / 6,299 Mixed M 41.07M 526 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 1,916 / 61,235 Mixed M and F 48.93M 525 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 735 / 32,896 Mixed F 49.27M 341 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 1,181 / 28,339 Mixed M 48.35M 611 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 1,712 / 457,538 European M and F 38.06M 468 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 655 / 248,644 European F 38.11M 297 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 1,057 / 208,894 European M 37.98M 483 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive 1,712 / 12,342 European M and F 37.33M 515 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive 655 / 6,741 European F 30.62M 310 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive 1,057 / 5,601 European M 29.42M 266 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 1,712 / 56,988 European M and F 38.10M 518 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 655 / 30,588 European F 38.08M 375 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 1,057 / 26,400 European M 37.94M 412 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 204 / 27,866 Non European M and F 66.62M 620 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive 204 / 1,480 Non European M and F 32.66M 247 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 204 / 4,247 Non European M and F 46.01M 331 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 62 / 10,947 Other M and F 61.41M 475 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive 62 / 433 Other M and F 20.49M 258 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 62 / 1,453 Other M and F 29.72M 230 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 65 / 9,352 South Asian M and F 41.98M 190 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive 65 / 628 South Asian M and F 15.97M 109 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 65 / 1,566 South Asian M and F 21.84M 67 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Severe Positive vs. Non-Severe Positive or Negative or Untested 935 / 486,385 Mixed M and F 47.70M 487 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Severe Positive vs. Non-Severe Positive or Negative or Untested 320 / 263,909 Mixed F 47.88M 390 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Severe Positive vs. Non-Severe Positive or Negative or Untested 615 / 222,476 Mixed M 47.45M 345 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Severe Positive vs. Non-Severe Positive 935 / 14,803 Mixed M and F 51.30M 713 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Severe Positive vs. Non-Severe Positive 320 / 7,938 Mixed F 42.94M 445 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Severe Positive vs. Non-Severe Positive 615 / 6,865 Mixed M 41.07M 432 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Severe Positive vs. Non-Severe Positive or Negative 935 / 62,216 Mixed M and F 48.93M 585 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Severe Positive vs. Non-Severe Positive or Negative 320 / 33,311 Mixed F 49.27M 368 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Severe Positive vs. Non-Severe Positive or Negative 615 / 28,905 Mixed M 48.35M 502 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Severe Positive vs. Non-Severe Positive or Negative or Untested 848 / 458,402 European M and F 38.06M 440 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Severe Positive vs. Non-Severe Positive or Negative or Untested 283 / 249,016 European F 38.11M 280 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Severe Positive vs. Non-Severe Positive or Negative or Untested 565 / 209,386 European M 37.98M 341 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Severe Positive vs. Non-Severe Positive 848 / 13,206 European M and F 37.33M 292 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Severe Positive vs. Non-Severe Positive 283 / 7,113 European F 30.62M 185 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Severe Positive vs. Non-Severe Positive 565 / 6,093 European M 29.42M 308 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Severe Positive vs. Non-Severe Positive or Negative 848 / 57,852 European M and F 38.10M 462 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Severe Positive vs. Non-Severe Positive or Negative 283 / 30,960 European F 38.08M 228 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.24.21 Severe Positive vs. Non-Severe Positive or Negative 565 / 26,892 European M 37.94M 405 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.02.21 Positive vs. Negative (tested) 13,232 / 41,374 European M and F 38.10M 526 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.02.21 Positive vs. Population 13,232 / 446,018 European M and F 38.06M 804 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.02.21 Positive vs. Negative (tested) 14,802 / 43,990 Mixed M and F 48.99M 673 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.02.21 Positive vs. Population 14,802 / 472,518 Mixed M and F 47.70M 825 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.02.21 Positive vs. Negative (tested) 470 / 769 African M and F 29.23M 181 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.02.21 Positive vs. Population 470 / 7,174 African M and F 43.68M 313 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.02.21 Positive vs. Negative (tested) 638 / 905 South Asian M and F 21.37M 163 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.02.21 Positive vs. Population 638 / 8,779 South Asian M and F 41.98M 395 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.02.21 Positive vs. Negative (tested) 462 / 942 Other M and F 28.87M 419 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.02.21 Positive vs. Population 462 / 10,547 Other M and F 61.41M 540 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.02.21 Positive vs. Negative (tested) 1,570 / 2,616 Non European M and F 45.03M 343 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.02.21 Positive vs. Population 1,570 / 26,500 Non European M and F 66.62M 748 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.02.21 Positive vs. Negative (tested) 6,950 / 22,105 European F 38.07M 427 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.02.21 Positive vs. Population 6,950 / 242,349 European F 38.11M 461 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.02.21 Positive vs. Negative (tested) 7,762 / 23,548 Mixed F 49.36M 592 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.02.21 Positive vs. Population 7,762 / 256,467 Mixed F 47.88M 575 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.02.21 Positive vs. Negative (tested) 6,282 / 19,269 European M 37.95M 363 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.02.21 Positive vs. Population 6,282 / 203,669 European M 37.98M 433 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.02.21 Positive vs. Negative (tested) 7,040 / 20,442 Mixed M 48.32M 503 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 02.02.21 Positive vs. Population 7,040 / 216,051 Mixed M 47.45M 508 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive vs. Negative (tested) 12,014 / 39,737 European M and F 38.10M 518 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive vs. Population 12,014 / 447,236 European M and F 38.06M 770 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive vs. Negative (tested) 13,401 / 42,261 Mixed M and F 48.87M 679 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive vs. Population 13,401 / 473,919 Mixed M and F 47.70M 795 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive vs. Negative (tested) 395 / 730 African M and F 28.53M 227 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive vs. Population 395 / 7,249 African M and F 43.68M 318 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive vs. Negative (tested) 576 / 879 South Asian M and F 20.89M 95 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive vs. Population 576 / 8,841 South Asian M and F 41.98M 361 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive vs. Negative (tested) 416 / 915 Other M and F 28.31M 269 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive vs. Population 416 / 10,593 Other M and F 61.41M 486 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive vs. Negative (tested) 1,387 / 2,524 Non European M and F 43.94M 322 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive vs. Population 1,387 / 26,683 Non European M and F 66.62M 642 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive vs. Negative (tested) 6,298 / 21,239 European F 38.06M 426 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive vs. Population 6,298 / 243,001 European F 38.11M 411 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive vs. Negative (tested) 7,005 / 22,634 Mixed F 49.24M 579 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive vs. Population 7,005 / 257,224 Mixed F 47.88M 528 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive vs. Negative (tested) 5,716 / 18,498 European M 37.97M 365 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive vs. Population 5,716 / 204,235 European M 37.98M 506 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive vs. Negative (tested) 6,396 / 19,627 Mixed M 47.82M 446 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive vs. Population 6,396 / 216,695 Mixed M 48.18M 530 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive and Death vs. Population 646 / 486,674 Mixed M and F 47.70M 386 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive and Death vs. Population 589 / 458,661 European M and F 38.06M 336 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive and Death vs. Positive Survivor 646 / 12,755 Mixed M and F 49.40M 540 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive and Death vs. Positive Survivor 589 / 11,425 European M and F 35.63M 269 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive and Death vs. Tested Survivor 646 / 55,016 Mixed M and F 48.87M 476 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Positive and Death vs. Tested Survivor 589 / 51,162 European M and F 38.10M 334 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 1,403 / 457,847 European M and F 38.06M 740 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Hospitalized Positive vs. Non-Hospitalized Positive 1,403 / 10,611 European M and F 35.63M 498 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 1,403 / 50,348 European M and F 38.10M 611 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 1,573 / 485,747 Mixed M and F 47.70M 552 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Hospitalized Positive vs. Non-Hospitalized Positive 1,573 / 11,828 Mixed M and F 49.40M 567 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 1,573 / 54,089 Mixed M and F 47.82M 559 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 170 / 27,900 Non European M and F 66.62M 552 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Hospitalized Positive vs. Non-Hospitalized Positive 170 / 1,217 Non European M and F 30.47M 180 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 170 / 3,741 Non European M and F 43.94M 319 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 529 / 248,770 European F 38.11M 323 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Hospitalized Positive vs. Non-Hospitalized Positive 529 / 5,769 European F 28.97M 241 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 529 / 27,008 European F 38.06M 359 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 600 / 263,629 Mixed F 47.88M 371 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Hospitalized Positive vs. Non-Hospitalized Positive 600 / 6,405 Mixed F 40.39M 339 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 600 / 29,039 Mixed F 49.02M 377 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 874 / 209,077 European M 37.98M 726 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Hospitalized Positive vs. Non-Hospitalized Positive 874 / 4,842 European M 27.83M 240 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 874 / 23,340 European M 37.97M 527 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 973 / 222,118 Mixed M 47.45M 745 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Hospitalized Positive vs. Non-Hospitalized Positive 973 / 5,423 Mixed M 38.54M 422 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 973 / 25,050 Mixed M 48.18M 677 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Severe Positive vs. Non-Severe Positive or Negative or Untested 666 / 458,584 European M and F 38.06M 364 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Severe Positive vs. Non-Severe Positive 666 / 11,348 European M and F 35.63M 311 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Severe Positive vs. Non-Severe Positive or Negative 666 / 51,085 European M and F 38.10M 373 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Severe Positive vs. Non-Severe Positive or Negative or Untested 737 / 486,583 Mixed M and F 47.70M 399 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Severe Positive vs. Non-Severe Positive 737 / 12,664 Mixed M and F 49.40M 567 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Severe Positive vs. Non-Severe Positive or Negative 737 / 54,925 Mixed M and F 48.87M 458 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Severe Positive vs. Non-Severe Positive or Negative or Untested 215 / 249,084 European F 38.11M 311 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Severe Positive vs. Non-Severe Positive 215 / 6,083 European F 28.97M 164 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Severe Positive vs. Non-Severe Positive or Negative 215 / 27,322 European F 38.06M 240 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Severe Positive vs. Non-Severe Positive or Negative or Untested 247 / 263,982 Mixed F 47.88M 400 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Severe Positive vs. Non-Severe Positive 247 / 6,758 Mixed F 40.39M 420 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Severe Positive vs. Non-Severe Positive or Negative 247 / 29,392 Mixed F 49.24M 427 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Severe Positive vs. Non-Severe Positive or Negative or Untested 451 / 209,500 European M 37.98M 353 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Severe Positive vs. Non-Severe Positive 451 / 5,265 European M 27.83M 284 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Severe Positive vs. Non-Severe Positive or Negative 451 / 23,763 European M 37.97M 481 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Severe Positive vs. Non-Severe Positive or Negative or Untested 490 / 222,601 Mixed M 47.45M 343 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Severe Positive vs. Non-Severe Positive 490 / 5,906 Mixed M 38.54M 346 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.22.21 Severe Positive vs. Non-Severe Positive or Negative 490 / 25,533 Mixed M 48.18M 507 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive vs. Negative (tested) 7,935 / 35,579 European M and F 38.09M 496 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive vs. Population 7,935 / 451,315 European M and F 38.06M 581 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive vs. Negative (tested) 8,722 / 37,939 Mixed M and F 48.59M 624 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive vs. Population 8,722 / 478,598 Mixed M and F 47.70M 652 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive vs. Negative (tested) 213 / 678 African M and F 26.91M 344 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive vs. Population 213 / 7,431 African M and F 43.68M 383 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive vs. Negative (tested) 351 / 836 South Asian M and F 19.32M 169 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive vs. Population 351 / 9,066 South Asian M and F 41.98M 335 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive vs. Negative (tested) 223 / 846 Other M and F 26.21M 521 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive vs. Population 223 / 10,786 Other M and F 61.41M 463 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive vs. Negative (tested) 787 / 2,360 Non European M and F 40.68M 334 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive vs. Population 787 / 27,283 Non European M and F 66.62M 587 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive vs. Negative (tested) 4,020 / 18,917 European F 38.03M 558 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive vs. Population 4,020 / 245,279 European F 38.11M 451 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive vs. Negative (tested) 4,405 / 20,226 Mixed F 49.02M 477 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive vs. Population 4,405 / 259,824 Mixed F 47.88M 395 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive vs. Negative (tested) 3,915 / 16,662 European M 37.93M 685 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive vs. Population 3,915 / 206,036 European M 37.98M 508 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive vs. Negative (tested) 4,317 / 17,713 Mixed M 47.82M 502 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive vs. Population 4,317 / 218,774 Mixed M 47.45M 504 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive and Death vs. Population 474 / 486,846 Mixed M and F 47.70M 590 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive and Death vs. Population 427 / 458,823 European M and F 38.06M 501 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive and Death vs. Positive Survivor 474 / 8,248 Mixed M and F 42.31M 568 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive and Death vs. Positive Survivor 427 / 7,508 European M and F 31.14M 435 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive and Death vs. Tested Survivor 474 / 46,187 Mixed M and F 48.59M 615 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Positive and Death vs. Tested Survivor 427 / 43,087 European M and F 38.09M 485 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 802 / 458,448 European M and F 38.06M 565 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Hospitalized Positive vs. Non-Hospitalized Positive 802 / 7,133 European M and F 31.14M 366 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 802 / 42,712 European M and F 38.09M 542 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 932 / 486,388 Mixed M and F 47.70M 447 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Hospitalized Positive vs. Non-Hospitalized Positive 932 / 7,790 Mixed M and F 42.31M 441 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 932 / 45,729 Mixed M and F 47.82M 502 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 130 / 27,940 Non European M and F 66.62M 564 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Hospitalized Positive vs. Non-Hospitalized Positive 130 / 657 Non European M and F 25.17M 125 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 130 / 3,017 Non European M and F 40.68M 274 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 299 / 249,000 European F 38.11M 292 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Hospitalized Positive vs. Non-Hospitalized Positive 299 / 3,721 European F 24.60M 157 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 299 / 22,638 European F 38.03M 294 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 357 / 263,872 Mixed F 47.88M 366 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Hospitalized Positive vs. Non-Hospitalized Positive 357 / 4,048 Mixed F 33.42M 289 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 357 / 24,274 Mixed F 49.02M 405 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 503 / 209,448 European M 37.98M 525 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Hospitalized Positive vs. Non-Hospitalized Positive 503 / 3,412 European M 24.26M 231 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 503 / 20,074 European M 37.93M 400 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 575 / 222,516 Mixed M 47.45M 756 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Hospitalized Positive vs. Non-Hospitalized Positive 575 / 3,742 Mixed M 32.73M 291 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 575 / 21,455 Mixed M 47.82M 676 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Severe Positive vs. Non-Severe Positive or Negative or Untested 482 / 458,768 European M and F 38.06M 518 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Severe Positive vs. Non-Severe Positive 482 / 7,453 European M and F 31.14M 408 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Severe Positive vs. Non-Severe Positive or Negative 482 / 43,032 European M and F 38.09M 420 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Severe Positive vs. Non-Severe Positive or Negative or Untested 541 / 486,779 Mixed M and F 47.70M 522 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Severe Positive vs. Non-Severe Positive 541 / 8,181 Mixed M and F 42.31M 592 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Severe Positive vs. Non-Severe Positive or Negative 541 / 46,120 Mixed M and F 48.59M 557 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Severe Positive vs. Non-Severe Positive or Negative or Untested 156 / 249,143 European F 38.11M 319 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Severe Positive vs. Non-Severe Positive 156 / 3,864 European F 24.60M 154 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Severe Positive vs. Non-Severe Positive or Negative 156 / 22,781 European F 38.03M 207 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Severe Positive vs. Non-Severe Positive or Negative or Untested 184 / 264,045 Mixed F 47.88M 334 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Severe Positive vs. Non-Severe Positive 184 / 4,221 Mixed F 33.42M 317 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Severe Positive vs. Non-Severe Positive or Negative 184 / 24,447 Mixed F 49.02M 444 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Severe Positive vs. Non-Severe Positive or Negative or Untested 326 / 209,625 European M 37.98M 419 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Severe Positive vs. Non-Severe Positive 326 / 3,589 European M 24.26M 158 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Severe Positive vs. Non-Severe Positive or Negative 326 / 20,251 European M 37.93M 319 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Severe Positive vs. Non-Severe Positive or Negative or Untested 357 / 222,734 Mixed M 47.45M 297 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Severe Positive vs. Non-Severe Positive 357 / 3,960 Mixed M 32.73M 254 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 01.04.21 Severe Positive vs. Non-Severe Positive or Negative 357 / 21,673 Mixed M 47.82M 369 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Negative (tested) 6,803 / 32,205 European M and F 38.07M 460 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Population 6,803 / 452,447 European M and F 38.06M 593 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Negative (tested) 7,435 / 34,362 Mixed M and F 48.51M 584 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Population 7,435 / 479,885 Mixed M and F 47.70M 688 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Negative (tested) 174 / 610 African M and F 26.07M 190 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Population 174 / 7,470 African M and F 43.68M 520 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Negative (tested) 282 / 773 South Asian M and F 18.50M 245 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Population 282 / 9,135 South Asian M and F 41.98M 366 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Negative (tested) 176 / 774 Other M and F 25.23M 368 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Population 176 / 10,833 Other M and F 61.41M 500 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Negative (tested) 632 / 2,157 Non European M and F 38.96M 413 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Population 632 / 27,438 Non European M and F 66.62M 635 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Negative (tested) 3,438 / 17,065 European F 37.99M 381 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Population 3,438 / 245,861 European F 38.11M 393 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Negative (tested) 3,752 / 18,252 Mixed F 48.95M 616 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Population 3,752 / 260,477 Mixed F 47.88M 552 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Negative (tested) 3,365 / 15,140 European M 37.92M 876 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Population 3,365 / 206,586 European M 37.98M 449 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Negative (tested) 3,683 / 16,110 Mixed M 47.72M 476 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Population 3,683 / 219,408 Mixed M 47.45M 458 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Negative (tested) 5,356 / 28,118 European M and F 38.05M 472 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Population 5,356 / 453,894 European M and F 38.06M 557 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Negative (tested) 5,868 / 30,028 Mixed M and F 48.59M 604 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Population 5,868 / 481,452 Mixed M and F 47.70M 644 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Negative (tested) 147 / 542 African M and F 25.24M 169 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Population 147 / 7,497 African M and F 43.68M 351 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Negative (tested) 232 / 685 South Asian M and F 17.60M 266 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Population 232 / 9,185 South Asian M and F 41.98M 315 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Negative (tested) 133 / 683 Other M and F 23.97M 328 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Population 133 / 10,876 Other M and F 61.41M 364 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Negative (tested) 512 / 1,910 Non European M and F 37.06M 387 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Population 512 / 27,558 Non European M and F 66.62M 688 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Negative (tested) 2,656 / 14,838 European F 37.95M 455 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Population 2,656 / 246,643 European F 38.11M 470 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Negative (tested) 2,906 / 15,886 Mixed F 49.09M 589 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Population 2,906 / 261,323 Mixed F 47.88M 508 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Negative (tested) 2,700 / 13,280 European M 37.85M 571 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Population 2,700 / 207,251 European M 37.98M 440 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Negative (tested) 2,962 / 14,142 Mixed M 47.67M 452 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Population 2,962 / 220,129 Mixed M 47.45M 428 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 3,962 / 25,845 European M and F 38.06M 427 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 3,962 / 455,288 European M and F 38.06M 500 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 4,372 / 27,629 Mixed M and F 48.73M 511 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 4,372 / 482,948 Mixed M and F 47.70M 648 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 130 / 508 African M and F 24.76M 154 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 130 / 7,514 African M and F 43.68M 352 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 180 / 645 South Asian M and F 16.96M 181 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 180 / 9,237 South Asian M and F 41.98M 290 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 100 / 631 Other M and F 23.15M 276 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 100 / 10,909 Other M and F 61.41M 420 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 410 / 1,784 Non European M and F 35.82M 374 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 410 / 27,660 Non European M and F 66.62M 477 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 1,953 / 13,591 European F 37.95M 348 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 1,953 / 247,346 European F 38.11M 363 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 2,159 / 14,564 Mixed F 42.21M 504 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 2,159 / 262,070 Mixed F 47.88M 395 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 2,009 / 12,254 European M 37.43M 397 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 2,009 / 207,942 European M 37.98M 491 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 2,213 / 13,065 Mixed M 47.81M 442 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 2,213 / 220,878 Mixed M 47.45M 521 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive and Death vs. Population 418 / 486,902 Mixed M and F 47.70M 450 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive and Death vs. Population 377 / 458,873 European M and F 38.06M 348 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive and Death vs. Positive Survivor 418 / 3,954 Mixed M and F 33.64M 298 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive and Death vs. Positive Survivor 377 / 3,585 European M and F 24.36M 202 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive and Death vs. Tested Survivor 418 / 31,583 Mixed M and F 48.73M 573 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive and Death vs. Tested Survivor 377 / 29,430 European M and F 38.07M 363 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 678 / 458,572 European M and F 38.06M 575 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive 678 / 3,284 European M and F 24.36M 271 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 678 / 29,129 European M and F 38.07M 524 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 794 / 486,526 Mixed M and F 47.70M 522 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive 794 / 3,578 Mixed M and F 33.64M 376 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 794 / 31,207 Mixed M and F 48.73MM 573 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 116 / 27,954 Non European M and F 66.62M 434 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive 116 / 294 Non European M and F 20.80M 140 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 116 / 2,078 Non European M and F 35.82M 227 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 246 / 249,053 European F 38.11M 311 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive 246 / 1,707 European F 19.11M 145 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 246 / 15,298 European F 37.95M 281 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 297 / 263,932 Mixed F 47.88M 378 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive 297 / 1,862 Mixed F 26.19M 151 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 297 / 16,426 Mixed F 49.21M 454 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 432 / 209,519 European M 37.98M 372 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive 432 / 1,577 European M 19.24M 187 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 432 / 13,831 European M 37.43M 424 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 497 / 222,594 Mixed M 47.45M 484 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive 497 / 1,716 Mixed M 25.51M 215 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 497 / 14,781 Mixed M 47.81M 532 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative or Untested 421 / 458,829 European M and F 38.06M 384 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive 421 / 3,541 European M and F 24.36M 200 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative 421 / 29,386 European M and F 38.07M 273 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative or Untested 474 / 486,846 Mixed M and F 47.70M 378 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive 474 / 3,898 Mixed M and F 33.64M 348 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative 474 / 31,527 Mixed M and F 48.73M 436 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative or Untested 146 / 249,153 European F 38.11M 276 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive 146 / 1,807 European F 19.11M 233 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative 146 / 15,398 European F 37.95M 269 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative or Untested 171 / 264,058 Mixed F 47.88M 441 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive 171 / 1,988 Mixed F 26.19M 235 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative 171 / 16,552 Mixed F 49.21M 488 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative or Untested 275 / 209,676 European M 37.98M 329 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive 275 / 1,734 European M 19.24M 168 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative 275 / 13,988 European M 37.43M 284 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative or Untested 303 / 222,788 Mixed M 47.45M 296 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive 303 / 1,910 Mixed M 25.51M 177 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative 303 / 14,975 Mixed M 47.81M 325 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 2,727 / 23,249 European M and F 38.03M 323 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 2,727 / 456,523 European M and F 38.06M 389 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 3,050 / 24,853 Mixed M and F 48.79M 426 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 3,050 / 484,270 Mixed M and F 47.70M 451 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 114 / 452 African M and F 24.05M 171 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 114 / 7,530 African M and F 43.68M 272 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 133 / 587 South Asian M and F 16.21M 173 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 133 / 9,284 South Asian M and F 41.98M 485 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 76 / 565 Other M and F 22.15M 179 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 76 / 10,933 Other M and F 61.41M 260 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 323 / 1,604 Non European M and F 34.25M 278 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 323 / 27,747 Non European M and F 66.62M 223 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 1,325 / 12,172 European F 36.92M 354 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 1,325 / 247,974 European F 38.11M 523 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 1,485 / 13,040 Mixed F 48.88M 422 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 1,485 / 262,744 Mixed F 47.88M 484 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 1,402 / 11,077 European M 36.05M 349 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 1,402 / 208,549 European M 37.98M 332 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 1,565 / 11,813 Mixed M 46.48M 406 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 1,565 / 221,526 Mixed M 47.45M 432 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive and Death vs. Population 416 / 486,904 Mixed M and F 47.70M 450 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive and Death vs. Population 375 / 458,875 European M and F 38.06M 365 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive and Death vs. Positive Survivor 416 / 1,405 Mixed M and F 25.98M 159 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive and Death vs. Positive Survivor 375 / 1,207 European M and F 17.85M 117 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive and Death vs. Tested Survivor 416 / 17,302 Mixed M and F 49.04M 722 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive and Death vs. Tested Survivor 375 / 16,068 European M and F 37.96M 442 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 1,582 / 14,861 European M and F 37.96M 333 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 1,582 / 457,668 European M and F 38.06M 419 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 1,821 / 15,897 Mixed M and F 49.04M 374 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 1,821 / 485,499 Mixed M and F 47.70M 437 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 96 / 288 African M and F 21.83M 102 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 96 / 7,548 African M and F 43.68M 311 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 80 / 362 South Asian M and F 13.89M 135 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 80 / 9,337 South Asian M and F 41.98M 548 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 63 / 386 Other M and F 19.92M 70 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 63 / 10,946 Other M and F 61.41M 189 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 239 / 1,036 Non European M and F 29.78M 250 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 239 / 27,831 Non European M and F 66.62M 238 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 736 / 7,709 European F 32.00M 311 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 736 / 248,563 European F 38.11M 482 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 851 / 8,271 Mixed F 42.92M 420 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 851 / 263,378 Mixed F 47.88M 300 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 846 / 7,152 European M 31.40M 311 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 846 / 209,105 European M 37.98M 459 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 970 / 7,626 Mixed M 40.61M 339 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 970 / 222,121 Mixed M 47.45M 708 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 1,503 / 10,632 European M and F 35.77M 344 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 1,503 / 457,747 European M and F 38.06M 408 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 1,723 / 11,409 Mixed M and F 47.68M 340 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 1723 / 485,597 Mixed M and F 47.70M 411 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 88 / 229 African M and F 20.84M 98 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 88 / 7,556 African M and F No change since 07.14.20 analysis
UKBB 08.04.20 Positive vs. Negative (tested) 73 / 254 South Asian M and F 12.77M 137 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 73 / 9,344 South Asian M and F 41.98M 636 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 59 / 294 Other M and F 18.49M 71 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 59 / 10,950 Other M and F 61.41M 121 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 220 / 777 Non European M and F 27.56M 209 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 220 / 27,850 Non European M and F 66.62M 315 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 699 / 5,452 European F 28.66M 205 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 699 / 248,600 European F 38.11M 352 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 804 / 5,887 Mixed F 39.16M 285 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 804 / 263,425 Mixed F 47.88M 315 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 804 / 5,180 European M 28.35M 300 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 804 / 209,147 European M 37.98M 450 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 919 / 5,522 Mixed M 37.00M 519 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 919 / 222,172 Mixed M 47.45M 590 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive and Death vs. Population 364 / 486,956 Mixed M and F 47.70M 437 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive and Death vs. Population 325 / 458,925 European M and F 38.06M 365 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive and Death vs. Positive Survivor 364 / 1,306 Mixed M and F 25.16M 127 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive and Death vs. Positive Survivor 325 / 1,129 European M and F 17.38M 130 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive and Death vs. Tested Survivor 364 / 8,874 Mixed M and F 47.70M 403 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive and Death vs. Tested Survivor 325 / 8,161 European M and F 31.99M 288 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 1,454 / 7,032 European M and F 31.99M 293 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 1,454 / 457,796 European M and F 38.06M 385 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 1,670 / 7,568 Mixed M and F 43.28M 304 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 1,670 / 485,650 Mixed M and F 47.70M 426 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 88 / 167 African M and F 19.75M 70 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 88 / 7,556 African M and F 43.68M 334 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 70 / 167 South Asian M and F 11.77M 69 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 70 / 9,347 South Asian M and F 41.98M 761 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 58 / 202 Other M and F 16.94M 46 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 58 / 10,951 Other M and F 61.41M 228 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 674 / 3,611 European F 25.20M 260 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 674 / 248,625 European F 38.11M 345 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 778 / 3,917 Mixed F 35.00M 371 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 778 / 263,451 Mixed F 47.88M 404 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 780 / 3,421 European M 25.03 244 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 780 / 209,171 European M 37.98M 393 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 892 / 3,651 Mixed M 32.98M 418 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 892 / 222,199 Mixed M 47.45M 597 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 1,291 / 5,455 European M and F 29.61M 304 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 1,291 / 457,959 European M and F 38.06M 379 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 1,485 / 5,877 Mixed M and F 40.32M 269 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 1,485 / 485,835 Mixed M and F 47.70M 395 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 77 / 135 African M and F 18.87M 93 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 77 / 7,567 African M and F 43.68M 293 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 64 / 135 South Asian M and F 11.29M 47 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 64 / 9,353 South Asian M and F 41.98M 722 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 53 / 152 Other M and F 15.58M 89 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 53 / 10,956 Other M and F 61.41M 200 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 610 / 2,779 European F 22.13M 228 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 610 / 248,689 European F 38.11M 447 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 701 / 3,014 Mixed F 32.30M 308 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 701 / 263,528 Mixed F 47.88M 265 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 681 / 2,676 European M 23.09M 338 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 681 / 209,270 European M 37.98M 337 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 784 / 2,863 Mixed M 30.60M 313 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 784 / 222,307 Mixed M 47.45M 419 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.05.20 Positive vs. Negative (tested) 1,221 / 4,117 European M and F 27.26 M 244 Summary Stats Annotated Grasp EBI GTeX eQTLdb
UKBB 06.05.20 Positive vs. Population 1,221 / 458,029 European M and F 38.06 M 406 Summary Stats Annotated Grasp EBI GTeX eQTLdb
UKBB 05.25.20 Positive vs. Negative (tested) 1,095/ 2,797 European M and F 24.33 M 172 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.25.20 Positive vs. Population 1,095 / 458,155 European M and F 38.06 M 448 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.07.20 Positive vs. Negative (tested) 880 / 1,686 European M and F 21.03 M 205 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.07.20 Positive vs. Population 880 / 458,370 European M and F 38.06 M 374 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 06.07.21 Very severe respiratory confirmed covid vs. population (A2) 8,779 / 1,001,875 Mixed M and F 8.14M 3800 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 06.07.21 Hospitalized covid vs. not hospitalized covid (B1) 14,480 / 73,191 Mixed M and F 13.50M 836 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 06.07.21 Hospitalized covid vs. population (B2) 24,274 / 2,061,529 Mixed M and F 11.81M 4732 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 06.07.21 Covid vs. population (C2) 112,612 / 2,474,079 Mixed M and F 12.22M 2263 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 01.07.21 Very severe respiratory confirmed covid vs. population (A2) 4,606 / 702,801 European M and F 9.86M 1057 Summary Stats Annotated Grasp EBI GTeX eQLdb A version of this analysis without UKBB is available on the Covid19-hg website
COVID19hg (link) 01.07.21 Very severe respiratory confirmed covid vs. population (A2) 5,870 / 1,155,203 Mixed M and F 7.54M 1009 Summary Stats Annotated Grasp EBI GTeX eQLdb A version of this analysis without UKBB is available on the Covid19-hg website
COVID19hg (link) 01.07.21 Hospitalized covid vs. not hospitalized covid (B1) 4,829 / 11,816 European M and F 8.38M 319 Summary Stats Annotated Grasp EBI GTeX eQLdb A version of this analysis without UKBB is available on the Covid19-hg website
COVID19hg (link) 01.07.21 Hospitalized covid vs. not hospitalized covid (B1) 5,773 / 15,497 Mixed M and F 7.67M 303 Summary Stats Annotated Grasp EBI GTeX eQLdb A version of this analysis without UKBB is available on the Covid19-hg website
COVID19hg (link) 01.07.21 Hospitalized covid vs. population (B2) 9,373 / 1,197,256 European M and F 8.15M 2794 Summary Stats Annotated Grasp EBI GTeX eQLdb A version of this analysis without UKBB is available on the Covid19-hg website
COVID19hg (link) 01.07.21 Hospitalized covid vs. population (B2) 12,888 / 1,295,966 Mixed M and F 7.58M 3390 Summary Stats Annotated Grasp EBI GTeX eQLdb A version of this analysis without UKBB is available on the Covid19-hg website
COVID19hg (link) 01.07.21 Covid vs. population (C2) 29,071 / 1,559,712 European M and F 8.74M 863 Summary Stats Annotated Grasp EBI GTeX eQLdb A version of this analysis without UKBB is available on the Covid19-hg website
COVID19hg (link) 01.07.21 Covid vs. population (C2) 36,590 / 1,668,938 Mixed M and F 8.17M 885 Summary Stats Annotated Grasp EBI GTeX eQLdb A version of this analysis without UKBB is available on the Covid19-hg website
Ellinghaus et al (link) 06.17.20 Covid-19 cases with respiratory failure vs Healthy controls 1,610 / 2,205 European M and F 8.58 M 391 Summary Stats Annotated Grasp EBI GTeX eQLdb GWAS adjusted for 10 PCs; Tops were lifted to hg19
Ellinghaus et al (link) 06.17.20 Covid-19 cases with respiratory failure vs Healthy controls 1,610 / 2,205 European M and F 8.58 M 317 Summary Stats Annotated Grasp EBI GTeX eQLdb GWAS adjusted for 10 PCs + age + sex; Tops were lifted to hg19
COVID19hg (link) 10.20.20 Very severe respiratory confirmed covid vs. not hospitalized covid (A1) 269 / 688 Mixed M and F 9.30M 81 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 10.20.20 Very severe respiratory confirmed covid vs. population (A2) 4,336 / 623,902 Mixed M and F 11.83M 949 Summary Stats Annotated Grasp EBI GTeX eQLdb These results do not include the 23andMe study. A limited version including 23andMe is available on the Covid19-hg website
COVID19hg (link) 10.20.20 Hospitalized covid vs. not hospitalized covid (B1) 2,430 / 8,478 Mixed M and F 14.90M 368 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 10.20.20 Hospitalized covid vs. population (B2) 6,406 / 902,088 European M and F 9.87M 2394 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 10.20.20 Hospitalized covid vs. population (B2) 7,885 / 961,804 Mixed M and F 11.43M 2748 Summary Stats Annotated Grasp EBI GTeX eQLdb These results do not include the 23andMe study. A limited version including 23andMe is available on the Covid19-hg website
COVID19hg (link) 10.20.20 Covid vs. lab/self-reported negative (C1) 11,085 / 116,794 Mixed M and F 13.06M 224 Summary Stats Annotated Grasp EBI GTeX eQLdb These results do not include the 23andMe study. A limited version including 23andMe is available on the Covid19-hg website
COVID19hg (link) 10.20.20 Covid vs. population (C2) 14,134 / 1,284,876 European M and F 11.58M 541 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 10.20.20 Covid vs. population (C2) 17,965 / 1,370,547 Mixed M and F 12.71M 396 Summary Stats Annotated Grasp EBI GTeX eQLdb These results do not include the 23andMe study. A limited version including 23andMe is available on the Covid19-hg website
COVID19hg (link) 10.20.20 Predicted covid from self-reported symptoms vs. predicted or self-reported non-covid (D1) 3,204 / 35,728 Mixed M and F 11.48M 88 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 09.30.20 Very severe respiratory confirmed vs. population (A2 alpha) 2,972 / 284,472 Mixed M and F 12.82M 886 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 09.30.20 Hospitalized covid vs. Not hospitalized covid (B1 alpha) 1,389 / 5,879 Mixed M and F 9.47M 66 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 09.30.20 Hospitalized covid vs. Population (B2 alpha) 6,492 / 1,012,809 Mixed M and F 10.53M 978 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 09.30.20 Covid vs. Lab/self-reported negative (C1 alpha) 11,181 / 116,456 Mixed M and F 13.91M 247 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 09.30.20 Covid vs. Population (C2 alpha) 17,607 / 1,345,334 Mixed M and F 13.06M 476 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 09.30.20 Predicted covid from self-reported symptoms vs. Predicted or self-reported non-covid (D1 alpha) 1,777 / 18,895 Mixed M and F 13.82M 106 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hgi (link) 06.26.20 Positive with severe respiratory vs. Population 536 / 329,391 Mixed M and F 9.31 M 60 Summary Stats Annotated Grasp EBI GTeX eQLdb Tops were lifted to hg19
COVID19hgi (link) 06.26.20 Positive Hospitalized vs. Positive Non Hospitalized 928 / 2,028 European M and F 12.03 M 130 Summary Stats Annotated Grasp EBI GTeX eQLdb Tops were lifted to hg19
COVID19hgi (link) 06.26.20 Positive Hospitalized vs. Population 3,199 / 897,488 Mixed M and F 15.39 M 453 Summary Stats Annotated Grasp EBI GTeX eQLdb Tops were lifted to hg19
COVID19hgi (link) 06.26.20 Positive vs. Lab/self reported Negative 3,523 / 36,634 Mixed M and F 22.04 M 153 Summary Stats Annotated Grasp EBI GTeX eQLdb Tops were lifted to hg19
COVID19hgi (link) 06.26.20 Positive vs. Population 6,696 / 1,073,072 Mixed M and F 20.59 M 377 Summary Stats Annotated Grasp EBI GTeX eQLdb Tops were lifted to hg19
COVID19hgi (link) 06.26.20 Positive (predict/self report) vs. Negative (predict/self report) 1,865 / 29,174 European M and F 12.27 M 169 Summary Stats Annotated Grasp EBI GTeX eQLdb Tops were lifted to hg19
COVID19hgi (link) 05.13.20 Positive Hospitalized vs. Positive Non Hospitalized 716 / 616 Mixed M and F 10.98 M 958 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hgi (link) 05.13.20 Positive vs. Population 1,678 / 674,635 Mixed M and F 34.01 M 3,262 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hgi (link) 05.13.20 Positive (predict/self report) vs. Negative (predict/self report) 1,294 / 26,969 European M and F 7.52 M 544 Summary Stats Annotated Grasp EBI GTeX eQLdb
GENOMICC(link) 12.11.20 Positive and critically ill vs. Population 1,676 / 8,280 European M and F 4.4M 650 Summary Stats Annotated Grasp EBI GTeX eQLdb Number of cases and controls inferred from the article
GENOMICC(link) 12.11.20 Positive and critically ill vs. Population 237 / 1,185 South Asian M and F 3.1M 1035 Summary Stats Annotated Grasp EBI GTeX eQLdb Number of cases and controls inferred from the article
GENOMICC(link) 12.11.20 Positive and critically ill vs. Population 182 / 910 African M and F 2.9M 261 Summary Stats Annotated Grasp EBI GTeX eQLdb Number of cases and controls inferred from the article
GENOMICC(link) 12.11.20 Positive and critically ill vs. Population 149 / 745 East Asian M and F 2.6M 235 Summary Stats Annotated Grasp EBI GTeX eQLdb Number of cases and controls inferred from the article
COLCORONA (link) 05.25.21 Time to end of COVID-19 symptoms in colchicine arm 872 European M and F 6.38M 86 Summary Stats Annotated Grasp EBI GTeX eQLdb
COLCORONA (link) 05.25.21 Time to end of COVID-19 symptoms in placebo arm 851 European M and F 6.38M 153 Summary Stats Annotated Grasp EBI GTeX eQLdb
COLCORONA (link) 05.25.21 Hospitalisation for COVID-19 in colchicine + placebo arms 58 / 1,797 European M and F 6.38M 146 Summary Stats Annotated Grasp EBI GTeX eQLdb
COLCORONA (link) 05.25.21 Time to end of COVID-19 symptoms in colchicine + placebo arms 1723 European M and F 6.38M 99 Summary Stats Annotated Grasp EBI GTeX eQLdb
COLCORONA (link) 05.25.21 Time to end of COVID-19 symptoms in males in colchicine + placebo arms 740 European M 6.38M 113 Summary Stats Annotated Grasp EBI GTeX eQLdb
COLCORONA (link) 05.25.21 Time to end of COVID-19 symptoms in females in colchicine + placebo arms 983 European F 6.38M 49 Summary Stats Annotated Grasp EBI GTeX eQLdb



This work was supported by the NHLBI Intramural Research program and the NIH Biowulf high performance computing cluster (https://hpc.nih.gov/).